We found that one potential mechanism driving NLRP3 hyperactivation in IPF-AE may be efferocytosis of apoptotic cells which led to increased NLRP3 expression and caspase-1 activation. The gene discussed is NLRP3; the disease is idiopathic pulmonary fibrosis.